Inflammatory bowel disease (IBD), which comprises of Crohn's disease and ulcerative
colitis, is an idiopathic relapsing and remitting disease in which the interplay of different …

The continuing identification of several epigenetic, transcriptomic, proteomic, and
metabolomic alterations in patients with IBD reflects the complex nature of the disease and …

Aim To assess the pathobiological and translational importance of whole-blood
transcriptomic analysis in inflammatory bowel disease [IBD]. Methods We analysed whole …

Background Crohn's disease (CD) and ulcerative colitis (UC) are intestinal chronic
inflammatory conditions characterized by altered epithelial barrier function and tissue …

Genomic technologies offer new approaches to the investigation of etiology and
pathophysiology of inflammatory bowel disease (IBD). Several areas of application for these …

Genetic, transcriptomic and epigenetic studies have offered exciting clues about IBD
pathogenesis but are unlikely to provide all answers. To fully grasp the function of disease …

The cases of inflammatory bowel disease (IBD) are increasing rapidly around the world. Due
to the multifactorial causes of IBD, there is an urgent need to understand the pathogenesis of …

Background Understanding the molecular pathogenesis of inflammatory bowel disease
(IBD) has led to the discovery of new therapeutic targets that are more specific and effective …

Perturbations in the intestinal microbiome are implicated in inflammatory bowel disease
(IBD). Studies of treatment-naive patients have identified microbial taxa associated with …

Abstract Background Inflammatory bowel diseases (IBDs) are characterized by chronic
inflammation and tissue damages in limited segments of the digestive tract. Pathogenesis in …